US2008233109A1PendingUtilityA1

Transgenic mammal carrying GANP gene transferred thereinto and utilization thereof

Assignee: IMMUNOKICK INCPriority: Nov 7, 2002Filed: Aug 17, 2007Published: Sep 25, 2008
Est. expiryNov 7, 2022(expired)· nominal 20-yr term from priority
Inventors:Nobuo Sakaguchi
C12N 2830/85C12N 15/8509A01K 2217/05A01K 67/0276A01K 2217/075C07K 16/40A61P 31/18A61P 31/14A01K 2267/01A01K 67/0275A01K 2267/03C07K 2317/92C12N 2830/15A01K 2227/105C07K 16/18A01K 67/027A61K 39/395C12N 15/09
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

It is an object of the present invention to provide a high affinity antibody effective as a diagnostic or therapeutic for various diseases; a transgenic mammal for producing the high affinity antibody; and a medicine comprising the high affinity antibody or a cell producing the high affinity antibody. According to the present invention, a transgenic mammal carrying a GANP gene transferred thereinto, its progeny, or a part thereof, and a method of producing a high affinity antibody using the same are provided.

Claims

exact text as granted — not AI-modified
1 . A high affinity antibody or a fragment thereof produced by a process of:
 administering an antigen to a transgenic non-human mammal or its progeny and recovering an antibody from the resultant mammal or progeny,   wherein said transgenic non-human mammal comprises a GANP gene.   
     
     
         2 . The antibody according to  claim 1 , wherein said antibody has an affinity of 1×10 −7  M or less as expressed as a dissociation constant, or a fragment thereof. 
     
     
         3 . The antibody according to  claim 1 , wherein said antibody is a polyclonal antibody or a monoclonal antibody, or a fragment thereof. 
     
     
         4 . The antibody according to  claim 1 , wherein said antibody is a humanized antibody or a human antibody, or a fragment thereof, and wherein said antibody comprises a V region of said antibody or a fragment thereof. 
     
     
         5 . A pharmaceutical composition comprising the antibody according to  claim 1 , or a fragment thereof. 
     
     
         6 . The pharmaceutical composition according to  claim 5 , wherein said antibody or a fragment thereof is a humanized antibody or a fragment thereof. 
     
     
         7 . The pharmaceutical composition according to  claim 5 , wherein said antibody or a fragment thereof is a human antibody or a fragment thereof.

Join the waitlist — get patent alerts

Track US2008233109A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.